Pantoprazole reduces serum ferritin in patients with thalassemia major and intermedia: A randomized, controlled study
Authors:
- 1 October 2019
- Vol. 74 (5) , 507-512
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Prevalence and distribution of iron overload in patients with transfusion‐dependent anemias differs across geographic regions: results from the CORDELIA studyEuropean Journal of Haematology, 2014
- Deferasirox reduces iron overload significantly in nontransfusion-dependent thalassemia: 1-year results from a prospective, randomized, double-blind, placebo-controlled studyBlood, 2012
- Complications of thalassemia major and their treatmentExpert Review of Hematology, 2011
- Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleedingHealth Technology Assessment, 2007
- Proton pump inhibitors suppress absorption of dietary non-haem iron in hereditary haemochromatosisGut, 2007
- Consequences of Long‐Term Proton Pump Blockade: Insights from Studies of Patients with GastrinomasBasic & Clinical Pharmacology & Toxicology, 2006
- Low Serum Ferritin Levels are Misleading for Detecting Cardiac Iron Overload and Increase the Risk of Cardiomyopathy in Thalassemia Patients. The Importance of Cardiac Iron Overload Monitoring Using Magnetic Resonance Imaging T2 and T2*Hemoglobin, 2006
- Effect of Omeprazole on Oral Iron Replacement in Patients with Iron Deficiency AnemiaSouthern Medical Journal, 2004
- PHYSIOLOGY AND MOLECULAR BIOLOGY OF DIETARY IRON ABSORPTIONAnnual Review of Nutrition, 2003
- Review article: metabolic consequences of long‐term inhibition of acid secretion by omeprazoleAlimentary Pharmacology & Therapeutics, 1992